Effects of the pre-existing coronary heart disease on the prognosis of COVID-19 patients: A systematic review and meta-analysis

被引:3
作者
Wang, Saikun [1 ]
Zhu, Ruiting [1 ]
Zhang, Chengwei [2 ]
Guo, Yingze [1 ]
Lv, Mengjiao [1 ]
Zhang, Changyue [1 ]
Bian, Ce [1 ]
Jiang, Ruixue [1 ]
Zhou, Wei [3 ]
Guo, Lirong [1 ]
机构
[1] Jilin Univ, Sch Nursing, Changchun, Jilin, Peoples R China
[2] Second Hosp Jilin Univ, Dept Anesthesiol, Changchun, Jilin, Peoples R China
[3] First Hosp Jilin Univ, Changchun, Jilin, Peoples R China
来源
PLOS ONE | 2023年 / 18卷 / 10期
关键词
CRITICALLY-ILL PATIENTS; CLINICAL CHARACTERISTICS; MYOCARDIAL INJURY; CRITICAL ILLNESS; MORTALITY; SEVERITY; OUTCOMES; DEATH; PREDICTORS; SARS-COV-2;
D O I
10.1371/journal.pone.0292021
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Although studies have shown severe Coronavirus disease 2019 (COVID-19) outcomes in patients with pre-existing coronary heart disease (CHD), the prognosis of COVID-19 patients with pre-existing CHD remains uncertain primarily due to the limited number of patients in existing studies. This study aimed to investigate the impacts of pre-existing CHD on the prognosis of COVID-19 patients. Five electronic databases were searched for eligible studies. This article focused on cohort and case-control studies involving the prognosis of COVID-19 patients with pre-existing CHD. The meta-analysis was performed using a random effects model. The odds ratios (ORs) and 95% confidence intervals (CIs) were used as valid indicators. The study was registered in PROSPERO with the identifier: CRD42022352853. A total of 81 studies, involving 157,439 COVID-19 patients, were included. The results showed that COVID-19 patients with pre-existing CHD exhibited an elevated risk of mortality (OR = 2.45; 95%CI: [2.04, 2.94], P < 0.001), severe/critical COVID-19 (OR = 2.57; 95%CI: [1.98, 3.33], P < 0.001), Intensive Care Unit or Coronary Care Unit (ICU/CCU) admission: (OR = 2.75, 95%CI: [1.61, 4.72], P = 0.002), and reduced odds of discharge/recovery (OR = 0.43, 95%CI: [0.28, 0.66], P < 0.001) compared to COVID-19 patients without pre-existing CHD. Subgroup analyses indicated that the prognosis of COVID-19 patients with pre-existing CHD was influenced by publication year, follow-up duration, gender, and hypertension. In conclusion, pre-existing CHD significantly increases the risk of poor prognosis in patients with COVID-19, particularly in those male or hypertensive patients.
引用
收藏
页数:22
相关论文
共 50 条
  • [31] Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk factors
    Yin, Tingxuan
    Li, Yuanjun
    Ying, Ying
    Luo, Zhijun
    BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [32] COVID-19 and Outcomes in Patients With Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
    Tripathi, Kartikeya
    Godoy Brewer, Gala
    Thu Nguyen, Minh
    Singh, Yuvaraj
    Saleh Ismail, Mohamed
    Sauk, Jenny S.
    Parian, Alyssa M.
    Limketkai, Berkeley N.
    INFLAMMATORY BOWEL DISEASES, 2022, 28 (08) : 1265 - 1279
  • [33] COVID-19 in patients with pre-existing chronic liver disease–predictors of outcomes
    Dinesh Walia
    Anoop Saraya
    Deepak Gunjan
    World Journal of Virology, 2023, (01) : 30 - 43
  • [34] Kidney Complications of COVID-19: A Systematic Review and Meta-Analysis
    Nasiri, Naser
    Rahmati, Shoboo
    Etminan, Abbas
    Sharifi, Hamid
    Bazrafshan, Azam
    Karamouzian, Mohammad
    Sharifi, Ali
    JOURNAL OF RESEARCH IN HEALTH SCIENCES, 2021, 21 (01) : 1 - 7
  • [35] Effect of Coronary Artery Disease on COVID-19-Prognosis and Risk Assessment: A Systematic Review and Meta-Analysis
    Szarpak, Lukasz
    Mierzejewska, Malgorzata
    Jurek, Jonasz
    Kochanowska, Anna
    Gasecka, Aleksandra
    Truszewski, Zenon
    Pruc, Michal
    Blek, Natasza
    Rafique, Zubaid
    Filipiak, Krzysztof J.
    Denegri, Andrea
    Jaguszewski, Milosz J.
    BIOLOGY-BASEL, 2022, 11 (02):
  • [36] Effects of corticosteroids on Covid-19 patients: A systematic review and meta-analysis on clinical outcomes
    Chaharom, Faegheh Ebrahimi
    Pourafkari, Leili
    Chaharom, Ali Asghar Ebrahimi
    Nader, Nader D.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2022, 72
  • [37] The association between pre-existing heart failure and cancer incidence: A systematic review and meta-analysis
    Barbosa, Carla
    Cabrita, Andre
    Dias, Camila
    Martins, Elisabete
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2024, 43 (07) : 399 - 414
  • [38] Effects of cancer on patients with COVID-19: a systematic review and meta-analysis of 63,019 participants
    Yang, Ludi
    Chai, Peiwei
    Yu, Jie
    Fan, Xianqun
    CANCER BIOLOGY & MEDICINE, 2021, 18 (01) : 298 - +
  • [39] Prevalence and prognosis of otorhinolaryngological symptoms in patients with COVID-19: a systematic review and meta-analysis
    Qiu, Jingjing
    Yang, Xin
    Liu, Limei
    Wu, Ting
    Cui, Limei
    Mou, Yakui
    Sun, Yan
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2022, 279 (01) : 49 - 60
  • [40] Effect of asthma, COPD, and ACO on COVID-19: A systematic review and meta-analysis
    Uruma, Yuka
    Manabe, Toshie
    Fujikura, Yuji
    Iikura, Motoyasu
    Hojo, Masayuki
    Kudo, Koichiro
    PLOS ONE, 2022, 17 (11):